Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Security class unavailable · CUSIP: 880881107
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,933,185
- Percent of class
- 2.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-098627
- Form type
- SC 13G
- Filer
- Terns Pharmaceuticals, Inc.
- CIK
- CIK 1831363
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership